Head and neck cancers in France: An analysis of the hospital medical information system (PMSI) database

Head and Neck Oncology

Volumn 2, Issue 1, 2010, Pages

  Lacau St Guily, Jean ^a   Borget, Isabelle ^b   Vainchtock, Alexandre ^c   Rémy, Vanessa ^d   Takizawa, Claire ^d  

^a HÔPITAL TENON   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HEVA   (France)

^d SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; FRANCE; HEAD AND NECK CANCER; HEALTH CARE FINANCING; HEALTH ECONOMICS; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LARYNX CANCER; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MOUTH CANCER; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PATIENT CARE; PHARYNX CANCER; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; TREATMENT DURATION; AGE; ECONOMICS; HEAD AND NECK TUMOR; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED;

AGE FACTORS; FEMALE; FRANCE; HEAD AND NECK NEOPLASMS; HOSPITAL COSTS; HOSPITAL INFORMATION SYSTEMS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77956897436     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-2-22     Document Type: Article

References (30)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. Cancer incidence and mortality in France over the period 1980-2005. A Belot P Grosclaude N Bossard E Jougla E Benhamou P Delafosse AV Guizard F Molinie A Danzon S Bara,, et al. Rev Epidemiol Sante Publique 2008 56 159 175 10.1016/j.respe.2008.03.117 18547762
3. Profiling early head and neck cancer. KD Hunter EK Parkinson PR Harrison, Nat Rev Cancer 2005 5 127 135 10.1038/nrc1549 15685196
4. [The frequency of cancer in France: mortality trends since 1950 and summary of the report on the causes of cancer]. C Hill F Doyon, Bull Cancer 2008 95 5 10 18230564
5. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? EM Sturgis PM Cinciripini, Cancer 2007 110 1429 1435 10.1002/cncr.22963 17724670
6. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. M Hashibe P Boffetta D Zaridze O Shangina N Szeszenia-Dabrowska D Mates E Fabianova P Rudnai P Brennan, Am J Epidemiol 2007 165 814 820 10.1093/aje/kwk066 17244634
7. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. ML Gillison, Semin Oncol 2004 31 744 754 10.1053/j.seminoncol.2004.09.011 15599852
8. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. AR Kreimer GM Clifford P Boyle S Franceschi, Cancer Epidemiol Biomarkers Prev 2005 14 467 475 10.1158/1055-9965.EPI-04-0551 15734974
9. Case-control study of human papillomavirus and oropharyngeal cancer. G D'Souza AR Kreimer R Viscidi M Pawlita C Fakhry WM Koch WH Westra ML Gillison, N Engl J Med 2007 356 1944 1956 10.1056/NEJMoa065497 17494927 (Pubitemid 46740304)
10. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? A Nasman P Attner L Hammarstedt J Du M Eriksson G Giraud S Ahrlund-Richter L Marklund M Romanitan D Lindquist,, et al. Int J Cancer 2009 125 362 366 10.1002/ijc.24339 19330833
11. HPV & head and neck cancer: a descriptive update. PK Goon MA Stanley J Ebmeyer L Steinstrasser T Upile W Jerjes M Bernal-Sprekelsen M Gorner HH Sudhoff, Head Neck Oncol 2009 1 36 10.1186/1758-3284-1-36 19828033
12. HPV infections and tonsillar carcinoma. S Syrjanen, J Clin Pathol 2004 57 449 455 10.1136/jcp.2003.008656 15113849
13. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. P Fouret G Monceaux S Temam L Lacourreye JL St Guily, Arch Otolaryngol Head Neck Surg 1997 123 513 516 9158399
14. Human papillomavirus in early laryngeal carcinoma. JL Baumann S Cohen AN Evjen JH Law S Vadivelu A Attia JS Schindler CH Chung PS Wirth CJ Meijer,, et al. Laryngoscope 2009 119 1531 1537 10.1002/lary.20509 19489068
15. Human papillomavirus vaccination in males. AR Giuliano, Gynecol Oncol 2007 107 24 26 10.1016/j.ygyno.2007.07.075 17938015
16. The cost-effectiveness of screening for oral cancer in primary care. PM Speight S Palmer DR Moles MC Downer DH Smith M Henriksson F Augustovski, Health Technol Assess 2006 10 1 144 iii-iv 16707071
17. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. K Lang J Menzin CC Earle J Jacobson MA Hsu, Arch Otolaryngol Head Neck Surg 2004 130 1269 1275 10.1001/archotol.130.11.1269 15545580
18. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. M van Agthoven BM van Ineveld MF de Boer CR Leemans PP Knegt GB Snow CA Uyl-de Groot, Eur J Cancer 2001 37 2204 2211 10.1016/S0959-8049(01)00292-1 11677108
19. Economic burden of head and neck cancer. A literature review. JM Lee M Turini MF Botteman JM Stephens CL Pashos, Eur J Health Econ 2004 5 70 80 10.1007/s10198-003-0204-3 15452768
20. Analyse économique des cots du cancer en France. INCa, Book Analyse économique des cots du cancer en France (Editor ed.^eds.). City 2007
21. Redressements du Programme de Médicalisation des Systèmes d'Informations (PMSI). Book Redressements du Programme de Médicalisation des Systèmes d'Informations (PMSI). (Editor ed.^eds.) City: Direction de la recherche, des études, de l'évaluation et des statistiques (DREES) 2005
22. SAE database 'Statistique Annuelle des Etablissements de santé'. Book SAE database 'Statistique Annuelle des Etablissements de santé' (Editor ed.^eds.). City 2004
23. BAQIMEHP, Book (Editor ed.^eds.). City 2004
24. Vulvar and vaginal cancers and dysplasia in France - an analysis of the hospital medical information system (PMSI) database. V Remy P Mathevet A Vainchtock, Eur J Obstet Gynecol Reprod Biol 2009 147 210 214 10.1016/j.ejogrb.2009.08.011 19735968
25. [Cost of colorectal cancer in France in 1999]. B Selke I Durand JP Marissal D Chevalier T Lebrun, Gastroenterol Clin Biol 2003 27 22 27 12594362
26. A cost analysis of Nd:YAG laser ablation versus endoscopic intubation for the palliation of malignant dysphagia. MJ Sculpher IR Sargeant LA Loizou SM Thorpe GM Spencer SG Bown, Eur J Cancer 1995 31A 1640 1646 10.1016/0959-8049(95) 00322-A 7488416
27. Mucositis in head and neck cancer: economic and quality-of-life outcomes. A Peterman D Cella G Glandon D Dobrez S Yount, J Natl Cancer Inst Monogr 2001 45 51 11694566
28. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis. N Penel JL Lefebvre JL Cazin S Clisant JC Neu B Dervaux Y Yazdanpanah, Int J Oral Maxillofac Surg 2008 37 135 139 10.1016/j.ijom.2007.08.002 18022348
29. Frequency and cost of thirty long-term disorders in the Midi-Pyrenees region in 2003. A Weill F Chinaud N Vallier R Bourrel C Suarez M Cayla, Revue Medicale de l'Assurance Maladie 2005 36 273 287
30. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. AK Chaturvedi EA Engels WF Anderson ML Gillison, J Clin Oncol 2008 26 612 619 10.1200/JCO.2007.14.1713 18235120